应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVOX 2倍做多NVO ETF-Defiance
盘前交易 02-04 07:13:46 EST
20.05
-8.35
-29.40%
盘前
18.91
-1.14
-5.69%
07:13 EST
最高
28.04
最低
19.71
成交量
258.63万
今开
27.81
昨收
28.40
日振幅
29.30%
总市值
5,610万
流通市值
5,610万
总股本
279.81万
成交额
5,597万
换手率
92.43%
流通股本
279.81万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和诺德CEO:Wegovy口服片的大幅普及完全证明了降价的合理性
格隆汇 · 18:42
诺和诺德CEO:Wegovy口服片的大幅普及完全证明了降价的合理性
Novo Nordisk:2025年Q4财报实现营收123.35亿美元,前值为122
智通财经 · 15:47
Novo Nordisk:2025年Q4财报实现营收123.35亿美元,前值为122
诺和诺德预计2026年销售额将下降5%至13%,为近九年来首次
华尔街见闻 · 05:07
诺和诺德预计2026年销售额将下降5%至13%,为近九年来首次
诺和诺德美国存托股因待发消息暂停交易
DoNews · 01:40
诺和诺德美国存托股因待发消息暂停交易
期权女巫 | 减肥药巨头诺和诺德被严重低估,可以考虑Short Put了
期权女巫 · 2025-08-25
期权女巫 | 减肥药巨头诺和诺德被严重低估,可以考虑Short Put了
加载更多
公司概况
公司名称:
2倍做多NVO ETF-Defiance
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":20.05,"timestamp":1770152400000,"preClose":28.4,"halted":0,"volume":2586265,"hourTrading":{"tag":"盘前","latestPrice":18.91,"preClose":20.05,"latestTime":"07:13 EST","volume":24227,"amount":448733.172356,"timestamp":1770207188427,"change":-1.14,"changeRate":-0.056858,"amplitude":0.080299},"delay":0,"changeRate":-0.2940140845070422,"floatShares":2798101,"shares":2798101,"eps":0,"marketStatus":"盘前交易","change":-8.35,"latestTime":"02-04 07:13:46 EST","open":27.81,"high":28.035,"low":19.7148,"amount":55971124.69773,"amplitude":0.292965,"askPrice":18.92,"askSize":750,"bidPrice":18.86,"bidSize":791,"shortable":0,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770215400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":20.05,"sharesOutstanding":2788101,"nav":28.34,"aum":79014782.34,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":18.91,"preClose":20.05,"latestTime":"07:13 EST","volume":24227,"amount":448733.172356,"timestamp":1770207188427,"change":-1.14,"changeRate":-0.056858,"amplitude":0.080299},"postHourTrading":{"tag":"盘后","latestPrice":18.9,"preClose":20.05,"latestTime":"19:59 EST","volume":100865,"amount":1947427.0609,"timestamp":1770166788605,"change":-1.15,"changeRate":-0.057357,"amplitude":0.098254},"volumeRatio":4.899478161126062,"impliedVol":0.8537,"impliedVolPercentile":0.5422},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"2608836889","title":"诺和诺德CEO:Wegovy口服片的大幅普及完全证明了降价的合理性","url":"https://stock-news.laohu8.com/highlight/detail?id=2608836889","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608836889?lang=zh_cn&edition=full","pubTime":"2026-02-04 18:42","pubTimestamp":1770201762,"startTime":"0","endTime":"0","summary":"格隆汇2月4日|诺和诺德(NVO.US)首席执行官:并不认为Wegovy口服片定价策略是一场豪赌,我们认为有责任让所有有需要的人获得我们生产的药物。Wegovy口服片的大幅普及完全证明了降价的合理性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204184326a47b8d9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204184326a47b8d9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","NVOX","NVOH","LU1093756168.USD","NVO","BK4007","LU0154236417.USD","BK4585","BK4532","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2608356638","title":"Novo Nordisk:2025年Q4财报实现营收123.35亿美元,前值为122","url":"https://stock-news.laohu8.com/highlight/detail?id=2608356638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608356638?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:47","pubTimestamp":1770191247,"startTime":"0","endTime":"0","summary":"Novo Nordisk(NVO.US):2025年Q4财报实现营收123.35亿美元,前值为122.59亿美元,预期值为120.8亿美元;每股收益为0.94美元,前值为0.91美元,预期值为0.89美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204160806a47aeea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204160806a47aeea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4532","LU0154236417.USD","LU1093756325.SGD","NVOX","NVOH","BK4007","LU1093756168.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","NVO","BK4585"],"gpt_icon":0},{"id":"2608238961","title":"诺和诺德预计2026年销售额将下降5%至13%,为近九年来首次","url":"https://stock-news.laohu8.com/highlight/detail?id=2608238961","media":"华尔街见闻","labels":["dataReport","movement"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608238961?lang=zh_cn&edition=full","pubTime":"2026-02-04 05:07","pubTimestamp":1770152829,"startTime":"0","endTime":"0","summary":"面临近十年来最严峻的业绩挑战。","market":"us","thumbnail":"https://static.tigerbbs.com/a53bfe57c284e33cd3bc632a37d7cb84","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a53bfe57c284e33cd3bc632a37d7cb84"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3764875","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3764875","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"超预期下滑!诺和诺德预计2026年销售恐降13%,美股跌超10%","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVO","NVOX"],"gpt_icon":1},{"id":"2608871403","title":"诺和诺德美国存托股因待发消息暂停交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871403","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608871403?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:40","pubTimestamp":1770140404,"startTime":"0","endTime":"0","summary":"2026年2月4日,诺和诺德公司美国存托股(ADRS)在美股市场暂停交易。暂停发生于纽约时间当日交易时段,主因为公司即将发布重要消息。诺和诺德总部位于丹麦哥本哈根,系全球领先的糖尿病与肥胖症药物研发企业。此次暂停交易由相关交易所依规执行,具体消息内容尚未公布。投资者正等待公司进一步公告以评估潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204014410a4786d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204014410a4786d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","NVOX","LU1093756168.USD","NVOH","NVO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","BK4007","BK4599","LU1093756325.SGD","BK4532","BK4588"],"gpt_icon":0},{"id":"1192804749","title":"期权女巫 | 减肥药巨头诺和诺德被严重低估,可以考虑Short Put了","url":"https://stock-news.laohu8.com/highlight/detail?id=1192804749","media":"期权女巫","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192804749?lang=zh_cn&edition=full","pubTime":"2025-08-25 14:26","pubTimestamp":1756103186,"startTime":"0","endTime":"0","summary":"$诺和诺德$ 当前被严重低估,滚动市盈率仅14倍,但其营收与盈利增速均超20%并占据减肥市场主导地位。诺和诺德与礼来共同主导减肥药市场,业务持续增长且利润率保持高位。过去12个月诺和诺德股价下跌约60%,说明对其的抛售可能过度。诺和诺德所处行业未来增长潜力巨大,若能维持市场主导地位,仅需求增长就能推动股价上涨。","market":"fut","thumbnail":"https://community-static.tradeup.com/news/45700f3d7074e4cc68c530b6eab404f5","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/45700f3d7074e4cc68c530b6eab404f5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d5ac29626454de4e6b59dd468043d74c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"减肥药巨头诺和诺德被严重低估,可以考虑Short Put了","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVO"],"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.3808},{"period":"1month","weight":-0.1324},{"period":"3month","weight":-0.0434},{"period":"6month","weight":-0.1049},{"period":"1year","weight":-0.7612},{"period":"ytd","weight":-0.0841}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}